Keeping You Updated
New Industry Dynamics to Help Secure the Right Deal
Oxford, UK- June 27 2011: PharmaDeals®, the publishing division of PharmaVentures, announced today the launch of PharmaDeals v4 Enterprise Edition, a new integrated resource with a comprehensive, searchable and interactive library of reports, articles, agreements, video, graphs and deal data. As well as access to new online content, the resource also provides users with a range of applications and tools for tracking, alerting and analysing information.
Fintan Walton, Chief Executive of PharmaVentures, the experts in deals and alliances, says, "Our research shows that pharma and biotech deal makers have to be increasingly more creative to secure the deals that count. Understanding the nature and extent of this new generation of deals is critical, as is a firm grasp of the established benchmarks and methodologies for deal making." Dr Walton continues, "Against this background, it's perhaps not surprising that our customers have expressed a need for a single point of access to our extensive range of deal making resources - whether it's a 'how to' guide, our expert analysis of trends, or direct access to the most comprehensive bank of industry data and agreements. But they want speed and ease of access too, irrespective of the type or source of information."
Anne Vindenes Allen, PharmaDeals' Executive Director, adds, "Our range of customers need to access and use our data and expertise in different ways, and this is addressed with PharmaDeals v4 Enterprise Edition. Market research, marketing and brand managers use the product to track competitors' deal making activities and stay apprised of the deal making arena. Business intelligence, business development, strategic planning and licensing executives use this vital information to empower their business decisions and benchmark deals. Furthermore, information about industry deals is valuable to R&D, discovery, financial institutions, and consultants. Through creating a fully online resource, and making it easier for our customers to see the full context through intelligent linking and classification, we have just made it possible for them to find all the key deal making information they need in one place". PharmaDeals are currently taking applications for company-wide demonstrations and trials to the new resource.
- ends -
About PharmaVentures
PharmaVentures is a premier transaction advisory firm; a world leader in partnering, M&A deals and strategic alliances. Our unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes us uniquely placed to support your business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.
Find out more www.pharmaventures.com
Our services include:
- M&A (divestments, mergers, acquisitions and strategic transactions)
- Strategy (commercialisation, deal strategy, due diligence, market entry)
- Valuation and Positioning (licensing, M&A, fund raising & expert testimonies)
- Licensing (in and out licensing)
- Expert Testimony (patent infringement, deal disagreements, taxation, determining damages)
Now in its 21st year, PharmaVentures is based in Oxford, UK, and employs over 17 people.
For further information, contact:
Dr Fintan Walton
CEO
PharmaVentures Ltd
+44 1865 332700
enquiries@pharmaventures.com